The role of 18F-FDG PET/CT in the evaluation of oesophageal carcinoma.
Clin Radiol
; 63(12): 1297-309, 2008 Dec.
Article
en En
| MEDLINE
| ID: mdl-18996259
ABSTRACT
Integrated positron-emission tomography/computed tomography (PET/CT) with 2-[fluorine-18] fluoro-2-deoxy-D-glucose (FDG) is now established in the management of oncology patients. With increasing availability and a constantly advancing body of evidence, the role of FDG PET/CT in oesophageal cancer is set to expand to include initial staging, assessment of disease response, therapy planning, and detection of disease recurrence. This article reviews the utility of FDG PET/CT in the management of oesophageal carcinoma, discussing its role and limitations in the imaging of these patients.
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Neoplasias Esofágicas
/
Carcinoma
/
Tomografía Computarizada de Emisión
/
Radiofármacos
/
Fluorodesoxiglucosa F18
/
Tomografía de Emisión de Positrones
Límite:
Female
/
Humans
/
Male
Idioma:
En
Revista:
Clin Radiol
Año:
2008
Tipo del documento:
Article
País de afiliación:
Reino Unido